Basic Info

Common Name3-Ethylphenol(F05633)
2D Structure
Description

3-Ethylphenol belongs to the family of Phenols and Derivatives. These are compounds containing a phenol moiety, which is a benzene bearing an hydroxyl group.

FRCD IDF05633
CAS Number620-17-7
PubChem CID12101
FormulaC8H10O
IUPAC Name

3-ethylphenol

InChI Key

HMNKTRSOROOSPP-UHFFFAOYSA-N

InChI

InChI=1S/C8H10O/c1-2-7-4-3-5-8(9)6-7/h3-6,9H,2H2,1H3

Canonical SMILES

CCC1=CC(=CC=C1)O

Isomeric SMILES

CCC1=CC(=CC=C1)O

Synonyms
        
            Phenol, 3-ethyl-
        
            3-ETHYLPHENOL
        
            620-17-7
        
            m-Ethylphenol
        
            Phenol, m-ethyl-
        
            meta-Ethylphenol
        
            1-Ethyl-3-hydroxybenzene
        
            1-Hydroxy-3-ethylbenzene
        
            3-Ethyl-phenol
        
            UNII-0G9ZK222JX
        
Classifies
                

                  
                    Predicted: Fungal Toxin
                  

                
        
Update DateNov 13, 2018 17:07

Chemical Taxonomy

KingdomOrganic compounds
SuperclassBenzenoids
ClassPhenols
Subclass1-hydroxy-4-unsubstituted benzenoids
Intermediate Tree NodesNot available
Direct Parent1-hydroxy-4-unsubstituted benzenoids
Alternative Parents
Molecular FrameworkAromatic homomonocyclic compounds
Substituents1-hydroxy-4-unsubstituted benzenoid - 1-hydroxy-2-unsubstituted benzenoid - Monocyclic benzene moiety - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Aromatic homomonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as 1-hydroxy-4-unsubstituted benzenoids. These are phenols that are unsubstituted at the 4-position.

Properties

Property NameProperty Value
Molecular Weight122.167
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count1
Complexity80.6
Monoisotopic Mass122.073
Exact Mass122.073
XLogP2.4
Formal Charge0
Heavy Atom Count9
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

ADMET

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9076
Human Intestinal AbsorptionHIA+0.9948
Caco-2 PermeabilityCaco2+0.8868
P-glycoprotein SubstrateNon-substrate0.6761
P-glycoprotein InhibitorNon-inhibitor0.9675
Non-inhibitor0.9662
Renal Organic Cation TransporterNon-inhibitor0.8721
Distribution
Subcellular localizationMitochondria0.7384
Metabolism
CYP450 2C9 SubstrateNon-substrate0.7108
CYP450 2D6 SubstrateNon-substrate0.8666
CYP450 3A4 SubstrateNon-substrate0.7014
CYP450 1A2 InhibitorInhibitor0.6932
CYP450 2C9 InhibitorNon-inhibitor0.7645
CYP450 2D6 InhibitorNon-inhibitor0.9333
CYP450 2C19 InhibitorNon-inhibitor0.6572
CYP450 3A4 InhibitorNon-inhibitor0.8252
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.6214
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.7889
Non-inhibitor0.9376
AMES ToxicityNon AMES toxic0.9470
CarcinogensNon-carcinogens0.6717
Fish ToxicityHigh FHMT0.7973
Tetrahymena Pyriformis ToxicityHigh TPT0.9798
Honey Bee ToxicityHigh HBT0.8192
BiodegradationNot ready biodegradable0.5987
Acute Oral ToxicityIII0.4678
Carcinogenicity (Three-class)Non-required0.5872

Model Value Unit
Absorption
Aqueous solubility-1.3170LogS
Caco-2 Permeability1.6122LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.2622LD50, mol/kg
Fish Toxicity1.0934pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.2007pIGC50, ug/L

Targets

General Function:
Zinc ion binding
Specific Function:
Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
Gene Name:
ESR1
Uniprot ID:
P03372
Molecular Weight:
66215.45 Da
References
  1. Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]